126 related articles for article (PubMed ID: 12517719)
1. Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury.
Stephanou A
Eur Cytokine Netw; 2002; 13(4):401-3. PubMed ID: 12517719
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis.
Townsend PA; Scarabelli TM; Pasini E; Gitti G; Menegazzi M; Suzuki H; Knight RA; Latchman DS; Stephanou A
FASEB J; 2004 Oct; 18(13):1621-3. PubMed ID: 15319365
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis.
Janjua S; Stephanou A; Latchman DS
Cell Death Differ; 2002 Oct; 9(10):1140-6. PubMed ID: 12232802
[TBL] [Abstract][Full Text] [Related]
4. The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes.
Stephanou A; Scarabelli TM; Townsend PA; Bell R; Yellon D; Knight RA; Latchman DS
FASEB J; 2002 Nov; 16(13):1841-3. PubMed ID: 12223448
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
6. Signaling networks regulating cardiac myocyte survival and death.
Wagner M; Siddiqui MA
Curr Opin Investig Drugs; 2009 Sep; 10(9):928-37. PubMed ID: 19705335
[TBL] [Abstract][Full Text] [Related]
7. STAT signalling in the heart and cardioprotection.
Soond SM; Latchman DS; Stephanou A
Expert Rev Mol Med; 2006 Jul; 8(15):1-16. PubMed ID: 16836797
[TBL] [Abstract][Full Text] [Related]
8. Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway.
Engelbrecht AM; Engelbrecht P; Genade S; Niesler C; Page C; Smuts M; Lochner A
J Mol Cell Cardiol; 2005 Dec; 39(6):940-54. PubMed ID: 16216266
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
[TBL] [Abstract][Full Text] [Related]
10. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction.
Bueno OF; Lips DJ; Kaiser RA; Wilkins BJ; Dai YS; Glascock BJ; Klevitsky R; Hewett TE; Kimball TR; Aronow BJ; Doevendans PA; Molkentin JD
Circ Res; 2004 Jan; 94(1):91-9. PubMed ID: 14615291
[TBL] [Abstract][Full Text] [Related]
12. MR image-guided investigation of regional signal transducers and activators of transcription-1 activation in a rat model of focal cerebral ischemia.
West DA; Valentim LM; Lythgoe MF; Stephanou A; Proctor E; van der Weerd L; Ordidge RJ; Latchman DS; Gadian DG
Neuroscience; 2004; 127(2):333-9. PubMed ID: 15262323
[TBL] [Abstract][Full Text] [Related]
13. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning.
Smith RM; Suleman N; Lacerda L; Opie LH; Akira S; Chien KR; Sack MN
Cardiovasc Res; 2004 Sep; 63(4):611-6. PubMed ID: 15306216
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
15. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
Hausenloy DJ; Yellon DM
Cardiovasc Res; 2004 Feb; 61(3):448-60. PubMed ID: 14962476
[TBL] [Abstract][Full Text] [Related]
16. Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury.
Stephanou A
J Cell Mol Med; 2004; 8(4):519-25. PubMed ID: 15601580
[TBL] [Abstract][Full Text] [Related]
17. Amino acid supplementation differentially modulates STAT1 and STAT3 activation in the myocardium exposed to ischemia/reperfusion injury.
Scarabelli TM; Townsend PA; Chen Scarabelli C; Yuan Z; McCauley RB; Di Rezze J; Patel D; Putt J; Allebban Z; Abboud J; Chilukuri K; Gardin J; Saravolatz L; Knight RA; Latchman DS; Stephanou A
Am J Cardiol; 2008 Jun; 101(11A):63E-68E. PubMed ID: 18514629
[TBL] [Abstract][Full Text] [Related]
18. Effects of phytoestrogen genistein on myocardial ischemia/reperfusion injury and apoptosis in rabbits.
Ji ES; Yue H; Wu YM; He RR
Acta Pharmacol Sin; 2004 Mar; 25(3):306-12. PubMed ID: 15000883
[TBL] [Abstract][Full Text] [Related]
19. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart.
Oshima Y; Fujio Y; Nakanishi T; Itoh N; Yamamoto Y; Negoro S; Tanaka K; Kishimoto T; Kawase I; Azuma J
Cardiovasc Res; 2005 Feb; 65(2):428-35. PubMed ID: 15639482
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of apoptosis in ischemic myocardium.
Scarabelli TM; Knight R; Stephanou A; Townsend P; Chen-Scarabelli C; Lawrence K; Gottlieb R; Latchman D; Narula J
Curr Probl Cardiol; 2006 Mar; 31(3):181-264. PubMed ID: 16503249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
